Isabel Rozas

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Topics

Molecular Dynamics Simulations

Staphylococcus Aureus

Metastatic Colorectal Cancer

Top Venues

Chemistry (Weinheim an der Bergstrasse, Germany)

Pharmaceuticals (Basel, Switzerland)

Microbiology spectrum

This page only lists publications with an associated author ORCID identifier.

Publications

Marco Minneci, Matas Misevicius, Isabel Rozas
Searching for "Greener" Bioequivalents of CF 3 to Lower its Environmental Impact. Chemistry (Weinheim an der Bergstrasse, Germany) (2024)
Barbara Farkaš, Marco Minneci, Matas Misevicius, Isabel Rozas
A Tale of Two Proteases: M Pro and TMPRSS2 as Targets for COVID-19 Therapies. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Marianne Rica Garcia, Iñigo Iribarren, Isabel Rozas, Cristina Trujillo
Simultaneous Hydrogen Bonds with Different Binding Modes: The Acceptor "Rules" but the Donor "Chooses". Chemistry (Weinheim an der Bergstrasse, Germany) (2023)
Darren Fergal Beirne, Barbara Farkaš, Chiara Donati, Valentina Gandin, Isabel Rozas, Trinidad Velasco-Torrijos, Diego Montagner
Novel design of dual-action Pt(IV) anticancer pro-drugs based on cisplatin and derivatives of the tyrosine kinase inhibitors imatinib and nilotinib. Dalton transactions (Cambridge, England : 2003) (2023)
Marianne Rica Garcia, Iñigo Iribarren, Isabel Rozas, Cristina Trujillo
Simultaneous Hydrogen Bonds with Different Binding Modes: The Acceptor "Rules" but the Donor "Chooses". Chemistry (Weinheim an der Bergstrasse, Germany) (2023)
Barbara Farkaš, Marco Minneci, Matas Misevicius, Isabel Rozas
A Tale of Two Proteases: M Pro and TMPRSS2 as Targets for COVID-19 Therapies. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
María Carmen Costas-Lago, Noemí Vila, Adeyemi Rahman, Pedro Besada, Isabel Rozas, José Brea, Maria Isabel Loza, Elisa González Romero, Carmen Terán
Novel Pyridazin-3(2 H )-one-Based Guanidine Derivatives as Potential DNA Minor Groove Binders with Anticancer Activity. ACS medicinal chemistry letters 13 (3) (2022)
Filippo Prencipe, Aishah M Alsibaee, Zainab Khaddem, Padraig Norton, Aisling M Towell, Afnan F M Ali, Gerard Reid, Orla M Fleury, Timothy J Foster, Joan A Geoghegan, Isabel Rozas, Marian P Brennan
Allantodapsone is a Pan-Inhibitor of Staphylococcus aureus Adhesion to Fibrinogen, Loricrin, and Cytokeratin 10. Microbiology spectrum 10 (3) (2022)
Viola Previtali, Helene B Mihigo, Rebecca Amet, Anthony M McElligott, Daniela M Zisterer, Isabel Rozas
Exploring the Anti-Cancer Mechanism of Novel 3,4'-Substituted Diaryl Guanidinium Derivatives. Pharmaceuticals (Basel, Switzerland) 13 (12) (2020)
Cristina Trujillo, Aoife Flood, Goar Sanchez-Sanz, Brendan Twamley, Isabel Rozas
Planarity or Nonplanarity: Modulating Guanidine Derivatives as α2-Adrenoceptors Ligands. Journal of chemical information and modeling 59 (5) (2019)
Viola Previtali, Cristina Trujillo, Rebecca Amet, Daniela M Zisterer, Isabel Rozas
Effect of isouronium/guanidinium substitution on the efficacy of a series of novel anti-cancer agents. MedChemComm 9 (4) (2018)
Cristina Trujillo, Pilar Goya, Isabel Rozas
Study of Meldrum's Acid Cyclization Reactions. The journal of physical chemistry. A 122 (9) (2018)
Adeyemi Rahman, Patrick O'Sullivan, Isabel Rozas
Recent developments in compounds acting in the DNA minor groove. MedChemComm 10 (1) (2018)